7.2.1.2  False Adverse Analytical Finding  for blind or double -blind EQAS  sample  In the event that a False Adverse Analytical Finding  is reported during the EQAS , WADA  will immediately start an investigation to establish if the incorrect result was caused by the EQAS  sample provider (blind and double -blind EQAS ) or the Testing  Authority  (double -blind EQAS ).